Obe-cel Elicits Durable Responses in Relapsed/Refractory B-Cell ALL
In the phase 1b/2 FELIX study, obecabtagene autoleucel was associated with low incidence of grade 3 or higher immune-related toxicity.
Related Articles
About
NCCN is a not-for-profit alliance of 33 leading cancer centers devoted to patient care, research, and education, is dedicated to improving and facilitating quality, effective,…
Advancing the Future of Diagnostics and Regulatory Innovations – Friends of Cancer Research
Advancing the Future of Diagnostics and Regulatory Innovations Tuesday, February 4, 2025 10AM – 2PM ET The Ritz Carlton 1150 22nd St NW, Washington, DC…
A Look at Poor Outcomes in Triple-Class Exposed Multiple… : Oncology Times
An abstract is unavailable.
Welcome! You are invited to join a webinar: [Live Webinar] – Optimising the management of HR+ HER2- metastatic breast cancer. After registering, you will receive a confirmation email about joining the webinar.
Join this webinar on Wednesday 22 January 2025, 19:00-20:00 CET, where Etienne Brain, Evandro de Azambuja, Valentina Guarneri, Cristina Saura and Hans Wildiers will discuss…
Classical Hematology Advancement Mentorship Program (CHAMP) – Hematology.org
Classical Hematology Advancement Mentorship Program (CHAMP)
Research and Education Fund Tiered Giving Program – Society of Surgical Oncology
Research and Education Fund Tiered Giving The Research and Education Fund (REF) Tiered Giving Program recognizes donors whose contributions since 2014 have collectively advanced cancer…
Dr Salani on Managing Mirvetuximab Soravtansine–Associated Ocular Toxicities in Ovarian Cancer
Ritu Salani, MD, MBA, discusses the management of ocular toxicities associated with mirvetuximab soravtansine in ovarian cancer.
Welcome! You are invited to join a webinar: [Live Webinar] – Optimising the management of HR+ HER2- metastatic breast cancer. After registering, you will receive a confirmation email about joining the webinar.
Join this webinar on Wednesday 22 January 2025, 19:00-20:00 CET, where Etienne Brain, Evandro de Azambuja, Valentina Guarneri, Cristina Saura and Hans Wildiers will discuss…
cfDNA screening for fetal aneuploidy facilitates maternal cancer detection
Nature Reviews Clinical Oncology – cfDNA screening for fetal aneuploidy facilitates maternal cancer detection
